Loading…

Statutory Instruments

2026 No. 207

NATIONAL HEALTH SERVICE, ENGLAND

The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2026

Made

3rd March 2026

Laid before Parliament

4th March 2026

Coming into force

1st April 2026

The Secretary of State makes these Regulations in exercise of the powers conferred by sections 6E (1) and (2) (a) and sections 272 (7) and (8) of the National Health Service Act 2006(1).

Citation, commencement, extent and application

1. These Regulations

(a)may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2026;

(b)come into force on 1st April 2026; and

(c)extend to England and Wales.

Amendment of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012

2.—(1) The National (Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Regulations 20122) are amended as follows.

(2) In , in regulation 20paragraph (1)(3)—

(a)in the definition of “flat rate payment”, for “£254.06” substitute “£267.68”;

(b)in the definition of “high band payment”, for £349.50” substitute “£368.24”.

Signed by authority of the Secretary of State for Health and Social Care

Stephen Kinnock

Minister of State

Department of Health and Social Care

3rd March 2026

(1)

2006 c. 41. Section 6E was inserted by section 20 (1) of the Health and Social Care Act 2012 (c. 7). Section 6E(1) was amended by section 78 (2) (a) of the Health and Care Act 2022 (c. 31). Sections 6E(1) and (2)(a) were amended by the Health and Care Act 2022 (c. 31), Schedule 1, paragraph 1(1) and Schedule 4, paragraph 89(3).

(2)

S.I. 2012/2996 (“the Standing Rules”) relevant amending instruments are S.I. 2013/261, 2014/1611, 2022/634, 2023/1071, 2024/302 and 2025/245. Under section 1 of the Health and Care Act 2022 (c. 31), the NHS Commissioning Board was renamed NHS England. On 1st July 2022, in accordance with Chapter A3 of Part 2 of the National Health Service Act 2006 (c. 41) (as inserted by section 19 of the Health and Care Act 2022) and S.I. 2022/632, NHS England established integrated care boards to take on the commissioning functions of clinical commissioning groups. As a consequence of those changes, paragraph 1 (1) of the Schedule to S.I. 2022/634 substitutes references to “clinical commissioning groups” with “integrated care board” in the Standing Rules. Paragraph 1 of the Schedule to S.I. 2023/1071 substitutes references to the “NHS Commissioning Board” with “NHS England” in the Standing Rules. There are other amending instruments but none is relevant.

(3)

Relevant amendments to regulation 20 were made by S.I. 2014/1611, 2024/302 and 2025/245.

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2026 (2026/207)
Version from: original only

Displaying information

Status of this instrument

in force Provision is in force
in force* In force only for specified purposes (for detail about the purposes see/hover footnote)
not in force Not in force in England (may be in force in other geographies, see footnotes)
italics Defined term
dfn Defined term (alternative style)
gry bckgrd the in-force status of the provision is complex, check the footnotes

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.